Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02958176 · ClinicalTrials.gov registry record · NA
Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder
A NA study of Female Sexual Arousal Disorder, sponsored by University of Texas at Austin.
- Completed
- Registry status
- NA
- Development phase
- 65
- Enrollment target
- 1
- Study location
NCT02958176 is a NA study of Female Sexual Arousal Disorder that has completed, run by University of Texas at Austin. The registered enrollment target is 65 participants. The trial reports 1 study location across 1 state.
The verdict
NCT02958176, a NA study of Female Sexual Arousal Disorder, has completed, sponsored by University of Texas at Austin.
- COMPLETED
- Registry status
- NA
- Development phase
- 65 participants
- Enrollment target
- 1
- Study location
Study Summary
Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which are comorbid with sexual arousal problems in women. Autogenic training also facilitates increases in HRV and was recently associated with acute increases in sexual arousal among sexually healthy women. The primary aim of the current study is to examine the efficacy of HRV biofeedback, with and without autogenic training, for the treatment of female sexual arousal disorder (FSAD).
Conditions Studied
Interventions
- BEHAVIORAL HRV Biofeedback
- BEHAVIORAL Autogenic Training
Study Locations (1)
Texas
- The University of Texas at Austin - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 65 participants |
| Start Date | 2016-10 |
| Est. Completion | 2018-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02958176
The ClinicalTrials.gov registry entry for NCT02958176 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 65 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Female Sexual Arousal Disorder appearing as the primary indexed condition, and to 2 interventions - of which HRV Biofeedback is the first listed.
NCT02958176 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.
Frequently Asked Questions
What is clinical trial NCT02958176 about?
NCT02958176 is a clinical study titled "Heart Rate Variability Biofeedback for Female Sexual Arousal Disorder". Low resting heart rate variability (HRV) has been associated with sexual arousal problems and overall sexual dysfunction in women. Research has indicated that HRV biofeedback leads to increases in HRV as well as improvements in symptoms associated with several psychological disorders, some of which ...
What is the current status of trial NCT02958176?
This trial is currently completed. It is a NA study. The enrollment target is 65 participants. The study started on 2016-10. Estimated completion is 2018-01.
What conditions does trial NCT02958176 study?
This clinical trial studies the following conditions: Female Sexual Arousal Disorder.
What interventions are being tested in trial NCT02958176?
The interventions under investigation include: HRV Biofeedback (BEHAVIORAL), Autogenic Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02958176?
This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02958176 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Female Sexual Arousal Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.